Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 1 views

    MPHR QQRM - Edited

    Uploaded by

    ashwinsmg2001

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    MPHR QQRM - Edited

    Uploaded by

    ashwinsmg2001
    1 views2 pages

    Original Title

    MPHR QQRM.edited

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    1 views2 pages

    MPHR QQRM - Edited

    Uploaded by

    ashwinsmg2001

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 2

    MPR135 Quantitative and Qualitative Research Method

    The Theranos Case

    The Theranos case is a cautionary tale about upholding ethical standards in research and

    business practices.

    Informed Consent: Theranos' CEO, Elizabeth Holmes, needed to obtain consent from

    participants in her company's blood-testing study. She promised that the technology could

    provide accurate and comprehensive blood test results with just a few drops of blood, but did

    not disclose the actual methods used to obtain these results. Participants were not informed

    about the limitations, such as the inability to detect certain diseases, risks like potential

    misdiagnosis, and potential errors like false positives, associated with the testing. This

    violation of informed consent principle is a serious breach of ethical standards.

    Research Misconduct: Theranos engaged in research misconduct by falsifying data,

    misrepresenting results, and manipulating studies to achieve desired outcomes. This

    manipulation led to publications in reputable scientific journals, which perpetuated the myth

    of the company's innovative technology.

    Non-Maleficence: Theranos actions also violated the principle of non-maleficence, which

    requires researchers to avoid causing harm to participants. The companies tests are often

    inaccurate, misleading, or incomplete, potentially leading to delayed or inadequate treatment

    for patients. This lack of transparency and accuracy caused unnecessary harm to patients and

    compromised their health and well-being.


    Transparency and Accountability: Research ethics require transparency and accountability

    in all stages of research, from study design to data collection and analysis. The lack of

    transparency at Theranos, including withholding information from regulators and the public,

    raises concerns about the integrity of the research conducted by the company.

    Privacy and Confidentiality: Researchers must protect the privacy and confidentiality of

    research participants' data. Theranos's handling of patient data raised concerns about privacy

    and confidentiality breaches, particularly if inaccurate results were shared without adequate

    consent or protection.

    The Theranos case underscores the critical importance of upholding research ethics principles

    in medical research. It serves as a stark reminder that prioritizing profit over patient welfare

    and compromising on ethical standards can have far-reaching and devastating consequences

    for patients and the scientific community as a whole. This is not just a lesson, but a call to

    action to ensure that such violations are not repeated.

    Submitted By

    Ashwin M B

    You might also like